Zn-DPA-maytansinoid conjugate 1

Zn-DPA-maytansinoid conjugate 1 是一种靶向小分子免疫检查点的类美坦素偶联物,可诱导肿瘤生长持续消退,并使肿瘤微环境 (TME) 恢复活力、转变为“发炎热肿瘤”。
产品编号: MS-H70326 CAS No.: 3034629-04-1 分子式: C115H145ClN18O31S2Zn2 分子量: 2505.83
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

Zn-DPA-maytansinoid conjugate 1 是一种靶向小分子免疫检查点的类美坦素偶联物,可诱导肿瘤生长持续消退,并使肿瘤微环境 (TME) 恢复活力、转变为“发炎热肿瘤”。

生物实验数据

生物活性 Zn-DPA-maytansinoid conjugate 1 is a maytansinoid-like conjugate targeting small-molecule immune checkpoints that induces sustained tumor growth regression and revitalizes the tumor microenvironment (TME), turning it into a "hot feverish tumor.
体外研究
(In Vitro)

Zn-DPA-maytansinoid conjugate 1 (compound 40a) (0-20 mM; 72 h) inhibits the growth of human pancreatic cancer MIA PaCa2 cells and triple-negative breast cancer HCC1806 cells and displays no effect on normal fibroblast (Detroit 551).
Zn-DPA-maytansinoid conjugate 1 increases CD8+ T cell infiltration significantly in the tumor mass that sensitized tumors from the intrinsic immune-suppressive TME.
Zn-DPA-maytansinoid conjugate 1 induces tumor inflammation-related mRNA expression such as STAT1, CXCL10, CCL5, and CCL2.
Zn-DPA-maytansinoid conjugate 1 leads to rejuvenation of TME with enhancement in T cell, macrophage, NK cell, chemokine, and cytokine functions.

Cell Viability Assay

Cell Line: Detroit 551, human pancreatic cancer MIA PaCa2 cells and triple-negative breast cancer HCC1806 cells
Concentration: 0-20 mM
Incubation Time: 72 hours
Result: Inhibited cancer cells with IC50s of 676 nM (MIA PaCa2) and 39 nM (HCC1806), respectively.
Showed low cytotoxicity against Detroit 551 cells (IC50>20 mM).
体内研究
(In Vivo)

Zn-DPA-maytansinoid conjugate 1 (compound 40a) (1-2.5 mg/kg; i.v.; twice a week for 2 weeks) effectively shrank the growth of many solid tumors, exerts antipancreatic cancer, anti-triple-negative breast cancer and anti-sorafenib-resistant HCC tumor activities.

Animal Model: Nude mice bearing MIA PaCa-2, HCC1806 or sorafenib-resistant HCC xenograft tumors, respectively
Dosage: 1 mg/kg, 2 mg/kg, 2.5 mg/kg
Administration: Intravenous injection; twice (day 1 and day 4) a week for 2 weeks; measured tumor twice weekly
Result: Resulted a lasting regression of tumor growth.
Animal Model: Male SD rats (8-week-old)
Dosage: 1 mg/kg
Administration: Intravenous injection; once a week for 4 weeks (days 1, 8, 15, and 22); measured body weights daily
Result: Showed no effect on rats body weight.
Animal Model: Pharmacokinetic study in ICR mice (6-week-old) bearing HCC1806 tumors
Dosage: 5 mg/kg (in 10% DMA/20% Cremophor EL/70% (5% dextrose))
Administration: Intravenous injection; single dose; collected blood samples at 0.003, 0.083, 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h and collected tumor samples at 0.5, 2, 6, 24, 72, and 168 h
Result: CL (mL/min/kg)=0.9; Vss (L/kg)=0.12; AUC (0-24 h) (ng/mL·h)=105599.

化学信息

分子量 2505.83
分子式 C115H145ClN18O31S2Zn2
CAS No. 3034629-04-1

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础